Hepcinat (Sofosbuvir Tablet) 400 mg

Hepcinat is an antiviral medication used in the treatment of chronic hepatitis C virus (HCV) infection. It is designed to lower the viral load and help eliminate the virus from the body.

• Chronic hepatitis C virus (HCV) infection: Helps in the treatment of chronic HCV infection in adults.
• HCV infection with liver cirrhosis: Used in patients with compensated or decompensated liver cirrhosis.
• HCV co-infection with HIV: Recommended for specific cases of HCV infection co-occurring with HIV.

• Sofosbuvir works by inhibiting the hepatitis C virus NS5B RNA-dependent RNA polymerase, causing chain termination of viral RNA synthesis. This action prevents the virus from replicating, thereby reducing the viral load in the body.

Hepcinat may cause several side effects, ranging from common to serious. It is important to be aware of these potential effects when using the medication.

Common Side Effects

• Fatigue: A feeling of tiredness or weakness.
• Headache: Pain or discomfort in the head or neck area.
• Nausea: A feeling of sickness in the stomach.
• Insomnia: Difficulty in falling or staying asleep.
• Diarrhea: Frequent, loose, or watery bowel movements.
• Irritability: A feeling of agitation or annoyance.

Serious or Rare Side Effects

• Anemia: A low number of red blood cells, which can cause fatigue and weakness.
• Skin rash: Redness, itching, or swelling of the skin.
• Itching: A sensation that causes a desire to scratch the skin.
• Serious allergic reactions: Symptoms may include rash, itching, swelling, severe dizziness, or trouble breathing.

Hepcinat should be used with caution, and certain precautions should be taken to ensure safe and effective treatment.

• Pregnancy: Not recommended for use during pregnancy due to potential risk to the unborn baby, especially when taken in combination with ribavirin.
• Breastfeeding: Caution is advised for breastfeeding women, as the safety of sofosbuvir in breastfeeding has not been established.
• Kidney impairment: Dosage adjustments may be required for patients with severe kidney disease or end-stage renal disease requiring dialysis.
• Liver function: Regular monitoring of liver function is recommended during treatment.
• Contraception: Women of childbearing potential must use reliable and effective contraception during treatment and for a period following the end of therapy.
• Store below 30°C: Keep in its original packaging, protected from light and moisture. Keep out of reach of children.

Hepcinat may interact with other medications, which can affect its effectiveness or increase the risk of side effects. It is important to be aware of these potential interactions.

Major Interactions (Avoid)

• Rifampin: May reduce the effectiveness of sofosbuvir.
• Phenobarbital: Can decrease the concentration of sofosbuvir in the blood.
• Carbamazepine: May reduce the effectiveness of sofosbuvir.
• St. John's Wort: Can decrease the concentration of sofosbuvir in the blood.
• Oxcarbazepine: May reduce the effectiveness of sofosbuvir.

Moderate Interactions (Monitor Closely)

• HIV protease inhibitors: May increase the risk of side effects when taken with sofosbuvir.
• Non-nucleoside reverse transcriptase inhibitors: May require monitoring for side effects.
• Other antiviral medications: May require dosage adjustments or monitoring for side effects.